• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cureus . Antigenic Variability a Potential Factor in Assessing Relationship Between Guillain Barr? Syndrome and Influenza Vaccine - Up to Date Lite

tetano

Editor, Senior Moderator
Cureus


. 2020 Sep 2;12(9):e10208.
doi: 10.7759/cureus.10208.
Antigenic Variability a Potential Factor in Assessing Relationship Between Guillain Barr? Syndrome and Influenza Vaccine - Up to Date Literature Review


Ravi Soni[SUP] 1 [/SUP], Stacey E Heindl[SUP] 2 [/SUP], Dwayne A Wiltshire[SUP] 3 [/SUP], Ilmaben S Vahora[SUP] 3 [/SUP], Safeera Khan[SUP] 3 [/SUP]



Affiliations

Abstract

Guillain-Barr? syndrome (GBS) is a possible serious adverse event of the influenza vaccine but it is yet to be proven. The objective of our traditional literature review is to assess the potential relationship between GBS and influenza vaccine. A traditional literature review has been carried out by selecting 26 articles from PubMed published between 2011 and 2020. Twenty-six articles met the selection criteria (eight observational studies, four systematic literature review, three meta-analyses, two case-control, two retrospective cohort, and seven case series). Selected studies were focused on monitoring the safety of influenza vaccines, the relative safety of pandemic and seasonal influenza vaccines, influenza vaccine a potential etiology of GBS, and pathogenesis of post-vaccination GBS. Few studies have shown a higher incidence of GBS with a pandemic influenza vaccine compared to the seasonal influenza vaccine, while several studies have concluded a small increase in the possibility of GBS following any type of influenza vaccine. There were some studies that estimated no association possibly due to the presence of confounding factors such as influenza-like illness, low power of the study, and reporting bias in post-vaccination surveillance programs. GSB should be taken into consideration as one of the less common but serious side effects of the influenza vaccine but it should not adversely affect the acceptance of the influenza vaccination program. Continuous monitoring of influenza vaccine safety should be performed regularly.

Keywords: gbs; guillain-barr? syndrome; influenza; influenza vaccine; influenza-like illness; pandemic influenza vaccine; seasonal influenza vaccine.
 
Back
Top Bottom